Tytti Massinen Email & Phone Number

Espoo, Uusimaa, Finland

Actim Oy is a Finnish biotechnology company that provides, develops, manufactures and markets diagnostic tests. The end-users of diagnostic tests are hospital laboratories, healthcare centers and medical clinics. Rapid tests form the majority of diagnostic products, in addition to which the businessalso includes instrument and controls, which are also used in in-house quality control. Actim Oy is subsidiary of Oy Medix Biochemica Ab and owned by DevCo Partners Oy and Minerva foundation.Responsibilities: -Overall responsibility for the customer relationship, contract negotiations, updating contractterms (including price revisions), budgeting, sales, reporting, and maintaining salesforecasts in their area of responsibility. -Responsible for mapping new market areas and partners in accordance with the company's strategy, and for implementing measures in accordance with the mapping. - Full coordination of customer relationship communication within the company.Highlights:- Contribution to the record year in the history of Actim, exceding the budged (+16 % total growth).- Nominated by the management team for Customer Success story of the year (+32% growth with the biggest European distributor).

Turku Area, Finland

Biovian is a biopharmaceutical CDMO focusing on Viral Vector production and microbial production of recombinant proteins. Guided by its Nordic ethos Biovian has established a reputation for delivering One-Stop-Shop services and manufacturing happiness to a global client base.Responsible for creating and executing a global marketing strategy to support business goals.o Lead the inbound marketing strategy and implementation of tactics - MQL and SQL lead generation, social selling.o Marketing mix strategy and development of competitive marketing collateral. o Website update project - 2020o Content creation - website content, expert blogs, press releases, articles, checklists and infographics.o Search engine optimization (SEO), Search engine marketing (SEM), YouTube optimization

Turku Area, Finland

Responsible for global product launch of Vanadis NIPT system.o Promotional activities i.e. conferences, user group meetings, workshops. o KOL customer visits to support local sales teams to reach their financial goals. Focusing on KOSEA+J, North America and distributor areas.o Customer Journey mapping to consolidate user requests.. o Product positioning and sales collateral together with MarCom team. o Training of key personnel with product knowledge. • Business partner in a cross functional team working with new RnD projects.• Management of product lifecycle by producing forecasts and reports to build the basis for business strategies and production plans.• Leading a small team of Associate Product manager(s).

• Egypt, Cairo November 10-11th 2019, CPHL One Health Approach: NIPT for All Women: Dream or reality?• Singapore September 10th 2019, ISPD. NIPT for All Women: Dream or reality?• ICRHC - Iran, Tehran May 19th 2016. Contingent NIPT and pre-eclampsia. • Morocco, Rabat Feb 20th 2016. A la Faculté de Médicine et de Pharmacie• Dépistage de la pré-eclampsie • Russia, Moscow Nov 6th 2013. Modern methods in prenatal diagnosis. • Placental Growth Factor in prenatal screening. • Ethiopia Addis Ababa, Oct 5th 2013, 1st FIGO Africa Regional conference of Gynaeocology and Obstetrics• Italy Palermo, May 13th2011, Primo trimester di gravidanza: Nuovi Protocolli di Screening• Finland Naantali, May 24th2011, Pre-eclampsia Symposium: Prenatal Risk Assessment of Pre- eclampsia & Future Directions in Maternal Health, National Congress of Perinatal Medicine • Italy Cagliari,May 15th 2010,10° Corso di Aggiornamento Teorico-Practico in Medicina Embrio- Fetale e Perinatale• Spain Barcelona, June 1st 2008, ESHG, European HUMAN GENETICS Conference

Finland

Commercialization of results of the world’s largest prospective, multicentric study about pre-eclampsia - The ASPRE study. o Branding of PerkinElmer’s PlGF assay as “the assay chosen by ASPRE”. Responsible for making a strategic business plan for sFLT-1 analyte for three diagnostic platforms.

United Arab Emirates

Responsible for sales of the Molecular diagnostics product portfolio from multiple vendors in the distributor area of GCC countries and for scientific product support across Prenatal Screening and Molecular Diagnostics products across the MENA territory.o Sales of the Molecular diagnostics product portfolio from multiple vendors in GCC countries.o Presentations at Medical congresses and local workshops (Iran, Morocco, Abu Dhabi, Jordan).o MoH and KOL-customer visits together with account managers to secure market entry or continuation of contracts with key accounts. o Application support and hands-on product training to new and existing laboratory customers.

•Responsible for developing and executing global strategic plans in Maternal Fetal Health area to meet market and financial objectives.•Provide strategic insight and direction to develop Maternal Health product portfolio (responsible for Business Development cases for e.g. Preterm birth, pre-eclampsia).•Core team member in New Product Development projects, ensuring projects are held to timelines, budget and product performance requirements. •Direct the development of company Marketing and Communication plan and the supporting sales activities (product launch, sales tools, education, Social media, web page content). •Establish relationships with Key Opinion Leaders and patient organizations/NGOs.•Support sales activities/account managers in Middle-East (2012-2013)

Finland

Product specialist• Shared responsibility for product launch of MAGDA CA rapid assay, used for microbiological food QC.• Account manager for 3M Pertifilm products.Responsibilities in technology transfer to production site in Lyon, France.Global launch activities as a Product specialist in 2006-2007. Product specialist responsibilities for new diagnostic pathogen products. Sales representative for 3M Petrifilm products in Finland

• Responsible for establishing a new diagnostics division within Raisio plc 2004. • Development of a rapid test for Salmonella detection (Patents US 12/085,898 and PTC/FI/2006/000403).

Microbiological and chemical quality control of food and feed products and raw materials (e.g. Benecol Functional Food products and cholesterol lowering ingredients). Experience from implementing HACCP in food production lines, from QC legislation and from working according the ISO certificate requirements.

Master Of Science

Executive Mba

Education record